Comparison between Canadian and British oncology drug review recommendations and their impact on patient access.

6537Background: Access and funding for oncology medications in Canada and the United Kingdom are influenced by recommendations released by the pan-Canadian Oncology Drug Review (pCODR) and the Nati...